The serine/threonine kinase AKT is frequently hyperactivated in breast cancer through multiple mechanisms, including PI3K activation, PTEN loss, and ErbB2/Her2/neu activation/amplification [51]. The gene discussed is ERBB2; the disease is breast cancer.